March 26 (Reuters) - WuXi Biologics (Cayman) Inc
:
* DOES NOT RECOMMEND ANY PAYMENT OF FINAL DIVIDEND
* FY PROFIT ATTRIBUTABLE RMB3,399.7 MILLION VERSUS RMB4,420.3 MILLION
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
March 26 (Reuters) - WuXi Biologics (Cayman) Inc
:
* DOES NOT RECOMMEND ANY PAYMENT OF FINAL DIVIDEND
* FY PROFIT ATTRIBUTABLE RMB3,399.7 MILLION VERSUS RMB4,420.3 MILLION
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Comments